A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

NCT00736073 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Pancreatitis

Interventions

DRUG: aprepitant
DRUG: Placebo

Sponsor

Duke University

Collaborators

[object Object]